The peptide C36L1, a 17-mer peptide that binds to CD74 on tumor-associated macrophages and DCs, was shown to block MIF’s immunosuppressive activities in melanoma models in vitro as well as in vivo [138]. Here, CD74 is linked to neoplasm.